Company
Accretion (noun): the process by which something strong is formed, layer upon layer, with each addition building on the last.
This is how we work: relentlessly, deliberately, and without wasted steps. We believe persistence, creativity, and a willingness to see problems differently can drive transformational change, and that belief fuels our formulation engineering as we work to bring new therapies to patients who have none.
Location
We are based in North Chicago, within one of the country's most concentrated corridors of pharmaceutical expertise.
Our offices are at Helix 51, an incubator within the Innovation and Research Park and Rosalind Franklin University of Science and Medicine. This gives us access to both the industrial discipline required to run a successful development program and onsite academic laboratories generating critical research that will advance the science.
Mission
Built by a network of experienced rare disease scientists, researchers, and other advocates, Accretion’s mission is to bring solutions to patients and families facing a rare disease diagnosis.
